Skip to content

Global Biobank Meta-analysis Initiative (GBMI)

Definition
AI-generated

The Global Biobank Meta-analysis Initiative (GBMI) is a large international effort that harmonizes genome-wide association analyses across many biobanks to increase discovery power and ancestral diversity for hundreds of disease endpoints.

Why it matters in GWAS

GBMI-type meta-analyses expand the evidence base beyond single mega-biobanks, improve representation of non-European participants in some traits, and provide resources for follow-up, fine-mapping, and polygenic score development—while still requiring care about heterogeneity and participation bias across sites.

Example usage

"We queried GBMI meta-analysis results for gout to complement our single-cohort discovery GWAS."

References

  • Zhou W, et al. (2022). Global biobank meta-analysis initiative: powering genetic discovery across human disease. Cell Genom.
  • Kuchenbaecker K, Navoly G. (2026). Ancestral diversity in complex disease genetics: from discovery to translation. Nat Rev Genet. https://doi.org/10.1038/s41576-025-00921-3

Last updated (UTC · Git history)